Can CA 19-9 predict inferior surgical and pathological outcomes for resectable pancreatic cancer?

被引：0
|
作者：
Jabbal, Iktej Singh
Nagarajan, Arun
Roy, Mayank
Rivera, Carlos
Yaghi, Marita
Liang, Hong
Nguyen, Timmy Q.
George, Tiffany L.
Nahleh, Zeina A.
Simpfendorfer, Conrad H.
机构：
[1] Cleveland Clin Florida, Weston, FL USA
[2] Cleveland Clin, Weston, FL USA
[3] Cleveland Clin Florida, Coral Springs, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16228
引用
收藏
页码：E16288 / E16288
页数：1
相关论文
共 50 条
  • [41] CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer
    Ishii, H
    Okada, S
    Sato, T
    Wakasugi, H
    Saisho, H
    Furuse, J
    Ishikawa, O
    Matsuno, S
    Yokoyama, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (13) : 279 - 283
  • [42] EVALUATION OF CA 19-9 LEVELS AS A MARKER FOR PANCREATIC-CANCER
    SHAW, NY
    HUTTON, JM
    DALBOW, MH
    SWANSON, PA
    BORDEN, KK
    CLINICAL CHEMISTRY, 1987, 33 (06) : 1034 - 1034
  • [43] Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary
    Pezzilli, R.
    Casadei, R.
    Calculli, L.
    Santini, D.
    Morselli-Labate, A. M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (01) : 73 - 74
  • [44] CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
    Werner Hartwig
    Oliver Strobel
    Ulf Hinz
    Stefan Fritz
    Thilo Hackert
    Constanze Roth
    Markus W. Büchler
    Jens Werner
    Annals of Surgical Oncology, 2013, 20 : 2188 - 2196
  • [45] ELEVATED CA 19-9 PREDICTS UNRESECTABLE PANCREATIC-CANCER
    LAMBIASE, L
    VOGEL, SB
    FORSMARK, CE
    GASTROENTEROLOGY, 1993, 104 (04) : A418 - A418
  • [46] CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
    Hartwig, Werner
    Strobel, Oliver
    Hinz, Ulf
    Fritz, Stefan
    Hackert, Thilo
    Roth, Constanze
    Buechler, Markus W.
    Werner, Jens
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2188 - 2196
  • [47] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: Second highest level of CA 19-9 in literature
    Kizilarslanoglu, Muhammet Cemal
    Civelek, Ramazan
    Kilic, Mustafa Kemal
    Kerem, Mustafa
    Gunaydin, Yusuf
    Ulger, Sukran
    JOURNAL OF BUON, 2014, 19 (02): : 583 - 584
  • [48] Prognostic Value of Preoperative CEA And CA 19-9 Levels in Resectable Gastric Cancer
    Dilege, Ece
    Mihmanli, Mehmet
    Demir, Uygar
    Ozer, Kadir
    Bostanci, Ozgur
    Kaya, Cemal
    Aksakal, Oeznur
    Sakiz, Damlanur
    HEPATO-GASTROENTEROLOGY, 2010, 57 (99-100) : 674 - 677
  • [49] CA 19-9 Response A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma
    Diaz, Celso L.
    Cinar, Pelin
    Hwang, Jimmy
    Ko, Andrew H.
    Tempero, Margaret A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (12): : 898 - 902
  • [50] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma - Reply
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5611 - 5611
12345